Abstract
Although muscarinic receptors are known to mediate tonic contraction of human gastrointestinal tract smooth muscle, the receptor subtypes that mediate the tonic contractions are not entirely clear. Whole human stomachs with attached esophagus were procured from organ transplant donors. Cholinergic contractile responses of clasp, sling, lower esophageal circular (LEC), midesophageal circular (MEC), and midesophageal longitudinal (MEL) muscle strips were determined. Sling fibers contracted greater than the other fibers. Total, M2 and M3 muscarinic receptor density was determined for each of these dissections by immunoprecipitation. M2 receptor density is greatest in the sling fibers, followed by clasp, LEC, MEC, and then MEL, whereas M3 density is greatest in LEC, followed by MEL, MEC, sling, and then clasp. The potency of subtype-selective antagonists to inhibit bethanechol-induced contraction was calculated by Schild analysis to determine which muscarinic receptor subtypes contribute to contraction. The results suggest both M2 and M3 receptors mediate contraction in clasp and sling fibers. Thus, this type of analysis in which multiple receptors mediate the contractile response is inappropriate, and an analysis method relating dual occupation of M2 and M3 receptors to contraction is presented. Using this new method of analysis, it was found that the M2 muscarinic receptor plays a greater role in mediating contraction of clasp and sling fibers than in LEC, MEC, and MEL muscles in which the M3 receptor predominantly mediates contraction.
Footnotes
-
This work was supported by the National Institutes of Health [Grant R01-DK059500].
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.108.148106.
-
ABBREVIATIONS: GEJ, gastroesophageal junction; HPZ, high-pressure zone; EFS, electric field stimulation; LES, lower esophageal sphincter; LEC, lower esophageal circular; MEC, midesophageal circular; MEL, midesophageal longitudinal; QNB, quinuclidinyl benzilate; TE, Tris-EDTA; TEDC, Tris-EDTA buffer containing 1% digitonin and 0.2% cholic acid; PLC, phospholipase C; DAR, darifenacin; METH, methoctramine; BETH, bethanechol; CRC, concentration response curve.
-
↵ The online version of this article (available at http://jpet.aspetjournals.org) contains supplemental material.
- Received November 3, 2008.
- Accepted January 5, 2009.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|